Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK
Crossref DOI link: https://doi.org/10.1136/bmjdrc-2019-000664
Published Online: 2019-09-03
Published Print: 2019-09
Update policy: https://doi.org/10.1136/crossmarkpolicy
Thalange, Nandu http://orcid.org/0000-0001-7925-625X
Gundgaard, Jens
Parekh, Witesh
Tutkunkardas, Deniz
Funding for this research was provided by:
Novo Nordisk A/S